Finance

TransCanada Corp says more layoffs on the way after cutting 10% of its staff in Q4

0211transcanada.jpg

CALGARY C TransCanada Corp. said Thursday more layoffs are expected as the energy sector grapples with plunging oil prices, after confirming it let go 10 % of workforce in the fourth quarter. The Calgary-based pipeline company let go staff in November, but did not provide numbers until Thursday’s earnings call to discuss fourth-quarter results. Chief financial officer Don Marchand said ...

Read More »

Bad news really is bad news: Turbulence tears through markets as investors lose faith central banks can save them

lme1.jpg

Financial markets are signaling that investors have lost faith in policy makers’ ability to support the global economy. Turbulence tore through global markets on Thursday as investors sought the safety of Japanese yen, gold and top-rated bonds. Europe got off to some torrid start, with Britain’s FTSE 100 down 2.3 per cent, Germany’s DAX 2.4 per cent lower and France’s ...

Read More »

Goldcorp Inc downgraded at Citi

0430chile.jpg

Goldcorp Inc. was downgraded to neutral from buy at Citi Research following disappointing fourth quarter earnings along with a weak production outlook. Analyst Brian Yu noted that Goldcorp has faced several obstacles in recent quarters, the most recent setback being the reclassification of their Cochenour project in Red Lake, Ont. This late-stage project is once more in the advanced exploration ...

Read More »

What to watch out for in Warren Buffett’s annual letter to investors, coming this Saturday

0226buffett.jpg

Here’s a theory from Charles Munger on why uncle Warren Buffett has been so successful building Berkshire Hathaway Inc. into one of the world’s most valuable companies: “He has considerable time to consider,” Munger told investors in Los Angeles on Feb. 10. “Warren is sitting on top of a business now, and you look at his schedule sometimes, and there’s ...

Read More »

Merus Labs stock tanks 16 per cent after acquisition

1128-biz-xfpcoal.jpg

Merus Labs International Inc.’s stock sunk 16 per cent Tuesday carrying out a $140 million deal to purchase the cardiovascular drug portfolio of the Belgium speciality pharma company. The Toronto-based company saw its shares fall 36 cents to $1.89, even as most analysts raised their price targets and maintained a buy rating around the stock. While analysts said the deal would ...

Read More »

How to escape the market meltdown mentality

meltdown.jpg

As I write, the world’s financial markets are experiencing their worst start to a new year ever. As is a fact of life throughout the most turbulent times, there’s truly nowhere to cover. Not in China. Not in Europe. Not within the U.S. And most not at all in Canada. ‘Ocean of fear’: Canadian investors located on record cash pile ...

Read More »

Canadian ETFs do record business in 2015 and more of the same expected in 2016 as mutual funds opt to join in

bmo1.jpg

While global stocks markets and economies will be in the doldrums recently, exchange-traded funds or ETFs did a booming business in 2015 and expect to make further inroads into the far older mutual fund business in 2016. ETFs still have no more than 10% of mutual fund assets but there are many signs Canada’s mutual fund industry in Canada is ...

Read More »

Few positives seen for Valeant Pharmaceuticals International Inc ahead of March 15 conference call

valeant1.jpg

Michael Pearson may still be considered by some because the best person to run Valeant Pharmaceuticals International Inc. moving forward, but that doesn’t mean the proportion price has room to operate higher in the near future. Investors and analysts expect Valeant will lower its 2016 revenue guidance if this holds a rescheduled conference call on March 15. However, the pharma ...

Read More »